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Experience with prevention programs in Thailand.
Background. Thailand is a developing country with a pop-
ulation of 62 million. It is estimated to have 1.6 million stage
3 or higher chronic kidney disease (CKD) patients. With lim-
ited funding for dialysis support, prevention of renal disease
progression is mandatory and urgently needed.
Methods. The Nephrology Society of Thailand has conducted
a survey among Thai nephrologists. The data were analyzed,
and a multidisciplinary team approach was introduced to make
patients more informed about CKD and more compliant with
dietary prescription.
Results. The survey showed that the majority of Thai nephrol-
ogists know about CKD guidelines. They regularly employed
several modes of drug therapy and appropriate target of blood
pressure control. However, only 38% and 5% of nephrologists
used multidisciplinary team approach and knew how to calcu-
late dietary protein intake, respectively, in CKD patients. To fa-
cilitate dietary counseling and care team approach, we invented
several dietary record forms (in Thai), Thai food exchange list,
7-day low-protein Thai food menu, and several patient edu-
cation guidebooks. We also set 1-day lecture tour courses for
physicians, nurses, and dieticians in various parts of the country.
At our own institute, we followed 17 CKD patients for 4 years:
the creatinine clearance (CCr) and glomerular filtration rate
(GFR) were 37.5 ± 5.5 and 24.4 ± 4.3 mL/min, respectively,
at the beginning, and were 35.7 ± 4.5 and 25.0 ± 3.5 mL/min,
respectively, 4 years thereafter. The rates of Ccr and GFR de-
cline were –0.5 ± 0.9 mL/min/year and 0.2 ± 0.6 mL/min/year,
respectively.
Conclusion. A combination of appropriate drug and dietary
therapy by employing a multidisciplinary team approach can
effectively delay renal disease progression.
Thailand is a developing country in Southeast Asia. It
has a population of 64 million and a gross per capita in-
come of approximately US $2200 per year. At present,
there are no epidemiologic studies of the prevalence of
early-stage chronic kidney disease (CKD) in Thailand.
Extrapolating from the NKF/DOQI guideline [1], ap-
proximately 4.2% of 20-year-old or older Thais (about
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2.7 million) might have decreased glomerular filtration
below 60 mL/min (stage 3 CKD).
The Nephrology Society of Thailand has conducted an
early, nationwide survey about renal replacement therapy
(RRT) for end-stage kidney disease. This is a voluntary-
response survey, and the data account for 70% of all RRT
in Thailand. We found that the prevalence of Thai patients
receiving maintenance dialysis therapy is 99 per million
population [2]. Comparing with the prevalence in other
developed countries, fewer-than-expected Thai CKD pa-
tients are under dialysis program. This is comprehensible
because the government and the social welfare system
can support the expense for just a portion of all Thai
end-stage CKD patients. Thus, effective preventive and
therapeutic programs to slow renal disease progression
are mandatory for Thai CKD patients.
The Nephrology Society of Thailand has just completed
another nationwide survey among 90 nephrologists re-
garding their knowledge and clinical practice patterns
for predialysis CKD patients (Table 1). The data show
that the majority (78%) of Thai nephrologists have read
the NKF/DOQI guidelines about CKD. Moreover, they
have already adopted regular use of phosphate binders,
bicarbonate therapy, and serum creatinine monitoring
for CKD patients. Only one third of them regularly pre-
scribe ACEi or angiotensin-receptor blockade, or utilized
creatinine clearance as monitoring index for CKD pa-
tients. Eighty percent of responding nephrologists regu-
larly gave dietary advice to their patients. Although there
are nutritional research centers in Thailand that are able
to produce many PhD and MSC graduates in Nutrition,
qualified dieticians at a bachelor degree level for clini-
cal service is still a scarcity in Thailand. It is alarming
that only 38% of Thai CKD patients have received di-
etary counseling by renal nurses. This probably reflects a
certain level of unawareness among nephrologists of ben-
eficial role of dietary control in CKD, as well as a lack of
multidisciplinary team and qualified personnel to relieve
the burden of overwhelming number of early-stage CKD
patients. Moreover, only 5% of Thai nephrologists had
an experience in calculation of dietary protein intake as
a part of clinical follow-up.
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Table 1. Assessment of clinical practice pattern among Thai
nephrologists for predialysis CKD patients
Learning about NKF/DOQI guidelines
The number of Thai nephrologists having read NKF/DOQI clinical
practice guidelines about chronic kidney disease—78%
Proportion of nephrologists who have:
Set target BP control within the “optimum” range (<130/80 mm Hg
or MAP <95 mm Hg)—72%
Used angiotensin-converting enzyme inhibitor or angiotensin
receptor blockade in at least 60% of CKD patients—36%
Used bicarbonate therapy in at least 60% of CKD patients—77%
Used phosphate binders in at least 60% of CKD patients—78%
Regularly employed serum creatinine as monitoring index (at least
× 3 per year) in at least 60% of CKD patients—94%
Regularly employed creatinine clearance as monitoring index (at
least × 3 per year) in at least 60% of CKD patients—43%
Provided dietary advice themselves in at least 60% of CKD
patients—82%
Provided dietary counseling by renal nurses or dieticians in at least
60% of patients—38%
Assessed dietary protein intake by dietary recall or protein nitrogen
appearance (PNA) calculation in at least 60% of patients—5%
At our institute, the King Chulalongkorn Memorial
Hospital, we have established a multidisciplinary team
approach to provide care for early-stage CKD patients.
Our team comprises nephrologists, renal nurses, and a
dietician. The optimum target for blood pressure control
((125/75 mm Hg), use of angiotensin-converting enzyme
inhibition, or angiotensin receptor blockade, if indicated,
phosphate binders, and control of metabolic acidosis with
bicarbonate therapy were employed in all cases. Patients
who smoked were encouraged to stop smoking. Dietary
protein intake was controlled at 0.6 to 0.8 g/kg/day. To
make the low-protein diet regimen and dietary counsel-
ing program comprehensible for our patients who had
little knowledge in nutrition, we developed our own di-
etary assessment record forms (in Thai), a table of food
exchange list of common ingredients used in Thai food
cooking, and a cabinet of food models comprising 45 va-
rieties of the common ingredients enlisted in our food
exchange list.
All cases were followed up at the outpatient clinic. Be-
side regular clinical and dietary assessment by the care
team, patients were instructed to have blood and 24-hour
urine collection. The serum biochemistries, creatinine
clearance, and 24-hour urine protein were monitored pe-
riodically. The glomerular filtration rate (GFR) was cal-
culated from an average of creatinine and urea clearances
[3].
After a mean follow-up of 4 years in 17 patients, there
is a slight increase in serum creatinine and a slight but not
significantly decrease in creatinine clearance. The GFR
and the GFR seem to be stable throughout the study
Table 2. Results of follow-up data in 17 CKD patients
After Rate of change
Parameter Before 4 years per year
Serum Cr mg/dL 2.85 ± 0.29 3.54 ± 0.33 0.17 ± 0.04
CCr mL/min 37.5 ± 5.5 35.7 ± 4.5 −0.5 ± 0.9
GFR mL/min 24.4 ± 4.3 25.0 ± 3.5 0.2 ± 0.6
24-hour urine protein g/day 1.0 ± 0.2 0.8 ± 0.2 −0.04 ± 0.05
Abbreviations are: Cr, creatinine; CCr, creatinine clearance; GFR, glomerular
filtration rate.
period. Thus, multidisciplinary team approach with strict
clinical practicing in accord with appropriate protocol is
beneficial for slowing the renal disease progression.
To facilitate utilization of a multidisciplinary team ap-
proach to provide care for Thai early-stage CKD patients,
the knowledge and technical know-how has been trans-
ferred to renal care teams in various parts of the country.
All together, more than 500 personnel (nephrologists, re-
nal and dialysis nurses, dietary specialist) have attended
seminars, conferences, and workshops organized by our
team. We plan to expand our training course to cover
more than 60% of all provincial hospitals in Thailand.
We also published and released more than 5000 copies of
clinical practice guideline recommendations for preven-
tion of progression of kidney disease. Another guideline
for prevention and care of diabetic nephropathy will be
released by the end of 2004.
With respect to patient education program, we have
just published 10,000 copies of a short manual on self-
assessment and care for early-stage CKD patients. These
pamphlets will be distributed to physicians, internists,
nephrologists, and CKD patients. We hope that with
strong and determined commitment to fight against CKD,
we can delay progression to end-stage kidney disease.
CONCLUSION
Active and intensive multidisciplinary care in CKD pa-
tients can effectively delay or even arrest renal disease
progression.
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